
1. trop doct. 2015 oct;45(4):231-5. doi: 10.1177/0049475514560211. epub 2014 dec 15.

hepatitis b c virus prevalence association demographics: report of
population screening nigeria.

onyekwere ca(1), hameed l(2).

author information: 
(1)senior lecturer/consultant gastroenterologist, lagos state university college 
of medicine/lagos state university teaching hospital ikeja, lagos, nigeria
ifymobi@yahoo.com.
(2)senior medical manager, medical affairs department, roche pharmaceuticals,
lagos, nigeria.

hepatitis b c remain major cause chronic liver disease worldwide with
its attendant consequences. burden viral infections sub-saharan
africa including nigeria rely estimates based small population studies in
some select populations. present report population survey nigeria 
during period 2010-2012. total 5,558 adults participated the
screening exercise. minimum age recorded 18 years, maximum age 
was 75 years. mean ± s.d. 36.07 ± 8.76 years. prevalence hepatitis
b (hbsag) among adults screened determined 6.7% of
hepatitis c (hcv) 0.9%. peak prevalence hbsag carriage the
third fourth decade keeping childhood acquisition hcv
antibody sixth seventh decade. male gender significantly
associated hbsag carriage noted higher prevalence within
the lower socioeconomic status. overall findings suggest hepatitis b 
endemic nigeria, much less previously reported, prevalence 
hcv low although reports pockets high prevalence exist select
populations (hospital patients including living hiv).

© author(s) 2014.

doi: 10.1177/0049475514560211 
pmid: 25515733  [indexed medline]

